
Dr Chiranjeev Singh Sethi
@chiranjeev96
Followers
371
Following
6K
Media
58
Statuses
2K
Doctor @aiims_newdelhi /Budding Medical Oncologist/Punjabi/#Medtwitter
New Delhi, India
Joined June 2010
RT @MarioBalsaMD: 💥 New @Nature study on lung cancer in never smokers (LCINS) reveals key mutational forces:. ⚠️ Air pollution (not secondh….
nature.com
Nature - An analysis of data from the Sherlock-Lung study provides insight into the mutational processes that contribute to lung cancer in never smokers, and looks at the possible role of factors...
0
18
0
RT @MarioBalsaMD: 🧬 New narrative review on 1L treatment for advanced NSCLC: ✅ IO ± chemo/dual IO improves outcome….
0
31
0
RT @kazuki_nozawa: Is surgery for the primary tumor in stage IV breast cancer beneficial? Only one trial from turkey was positive for prolo….
0
44
0
RT @lungoncdoc: Before and After. Just 8 weeks. Nope, not lymphoma. THIS is non-small cell lung cancer. THIS is why molecular profiling m….
0
90
0
RT @Geeky_Foodie: Don’t judge an oncologist for ordering multiple tests or repeat biopsies, when in doubt. It's not excessive, it's essenti….
0
21
0
RT @DrJayamadhuriMD: I, Dr Jaya Madhuri, am a doctor and an aspiring oncologist from Hyderabad. I'm writing to highlight the crisis faced b….
0
11
0
RT @DrShauryaGarg: Govt and institutions find ways to exploit its citizen. I mean exits are not even free for round1&2.🤦♂️🤦♂️.
0
7
0
RT @KapoorShagun10: 1️⃣ Allow Free Exit for NEET-SS Round 1 & 2 allottees who are opting for INI-SS seats. 2️⃣ Open Round 3 for all candida….
0
51
0
RT @DrAditya2935: You get AIR 1 in NEET SS. Counseling doesn’t start on time. You take Tata Memorial for med/Sx onc.But INI also comes -….
0
63
0
1️⃣ Allow Free Exit for NEET-SS Round 1 & 2 allottees who are opting for INI-SS seats. 2️⃣ Open Round 3 for all candidates so no seat goes wasted and merit is upheld. This is a call for fairness, not favor. #FairChanceForDoctors #NEETSS #INISS @MoHFW_INDIA @JPNadda.
0
37
89
RT @SuyogCancer: When you treat metastatic CRPC in elderly person, polypharmacy and drug to drug interactions needs to noted . These are s….
0
36
0
RT @NEJM: In women with node-positive breast cancer whose nodes became free of disease after neoadjuvant therapy, regional nodal irradiatio….
0
89
0
RT @DrYukselUrun: #FDA approves darolutamide for metastatic castration-sensitive #prostatecancer.@US_FDA @ASCO @APCCC_Lugano @OncoAlert #AS….
0
33
0
RT @PTarantinoMD: The curves everybody’s been waiting for. First line T-DXd + pertuzumab significantly prolonged PFS over THP for HER2+ M….
0
118
0
RT @GuiperiniMD: Most practice-changing Abstract in #EHA2025, in my opinion, might surprise some. Cyclophosphamide is the new SoC for LGL….
library.ehaweb.org
EHA Library; Lamy T. Jun 12 2025; 4159267;
0
12
0
RT @DrGauravNarula: Out now, our bit for Low Dose ImmunoRx #LoDoNiv in relapse/refractory Ped Classic Hodgkin cHL #PHLDMG @TataMemorial .Fi….
0
7
0